Roth MKM Maintains Buy on ChromaDex, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
Roth MKM analyst Sean McGowan maintains a Buy rating on ChromaDex (NASDAQ:CDXC) with a $6 price target.
June 12, 2024 | 3:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Roth MKM analyst Sean McGowan has reiterated a Buy rating for ChromaDex (NASDAQ:CDXC) and maintained a price target of $6.
The reiteration of a Buy rating and a maintained price target of $6 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100